$42.99 +0.95 (%) GlaxoSmithKline Shs Sponsored American Deposit Receipt Repr 2 Shs - NYSE

Dec. 18, 2014 | 10:16 AM

Partner Headlines

  1. Weekly 3-Year Low Highlights: RDS.B, GSK, WPZ, CLR

    GuruFocus | Dec. 14, 2014 | 21:52PM EST
  2. Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines

    Benzinga | Dec. 11, 2014 | 14:14PM EST
  3. Pfizer Spreading Its Wings Into A New Domain Of Life Sciences

    GuruFocus | Dec. 9, 2014 | 10:50AM EST
  4. Merck Bets $9.5 Billion On Cubist's War On Superbugs

    IBD | Dec. 8, 2014 | 18:49PM EST
  5. GlaxoSmithKline's Move A Testament That Pharma Companies Are Turning Focus Away From U.S.

    Benzinga | Dec. 1, 2014 | 11:58AM EST
  6. The Top 5 European Stocks Held During Q3

    GuruFocus | Nov. 25, 2014 | 18:19PM EST
  7. BioMarin buying Prosensa

    IBD | Nov. 24, 2014 | 18:43PM EST
  8. BioMarin Buying Prosensa, Backing Up Troubled Drug

    IBD | Nov. 24, 2014 | 10:22AM EST
  9. Screening Pharma Stocks Amid Turnaround

    YCharts | Nov. 19, 2014 | 09:37AM EST
  10. Jeff Auxier Buys Berkshire Hathaway in Third Quarter

    GuruFocus | Nov. 18, 2014 | 16:33PM EST
  11. Apollo may make Glaxo offer

    IBD | Nov. 13, 2014 | 18:37PM EST
  12. Irving Kahn Starts New Position In GlaxoSmithKline

    GuruFocus | Nov. 13, 2014 | 08:26AM EST
  13. Irving Kahn Buys Stake in GlaxoSmithKline During Q3 2014

    GuruFocus | Nov. 12, 2014 | 15:29PM EST
  14. Insys Q3 Beats Estimates, Helping Stock Rebound

    IBD | Nov. 11, 2014 | 11:33AM EST
  15. Kahn Brothers' Third Quarter Numbers

    GuruFocus | Nov. 7, 2014 | 17:43PM EST
  16. Ebola Vaccine Contenders

    Benzinga | Oct. 30, 2014 | 10:44AM EST
  17. Stock Futures Upshift On Data; Yahoo, Broadcom, Boeing Climb

    IBD | Oct. 22, 2014 | 09:01AM EST
  18. Benzinga Weekly Preview: Earnings Season Is In Full Swing

    Benzinga | Oct. 19, 2014 | 10:19AM EST
  19. Diamond Hill Capital Comments on GlaxoSmithKline PLC

    GuruFocus | Oct. 17, 2014 | 17:31PM EST
  20. Sarepta Therapeutics Shares Up On Ebola Drug Safety Study

    Benzinga | Oct. 17, 2014 | 10:58AM EST
  21. Hazmat Suit Maker Lakeland Soars On Dallas Ebola Fear

    IBD | Oct. 9, 2014 | 14:38PM EST
  22. Ebola-Related Pharma Stocks Soar On First U.S. Case

    IBD | Oct. 1, 2014 | 14:20PM EST
  23. Action Heats Up in Ebola-Related Equities

    FoxBusiness | Oct. 1, 2014 | 09:15AM EST
  24. Guru Stocks at 52-Week Lows: BHP, GSK, UTX, SAP, TEF

    GuruFocus | Sep. 30, 2014 | 13:10PM EST
  25. Pharma Stocks: Surprising Shift In U.S. Drug Market

    YCharts | Sep. 29, 2014 | 08:15AM EST
  26. Royal Bank of Scotland

    IBD | Sep. 25, 2014 | 18:53PM EST
  27. Gilead's New HIV Drug Key To Long-Term Strategy

    IBD | Sep. 24, 2014 | 17:29PM EST
  28. International Securities For A Diversified Income Portfolio

    GuruFocus | Sep. 23, 2014 | 13:36PM EST
  29. Could European Funds Offer An Opportunity Now?

    Benzinga | Sep. 23, 2014 | 10:04AM EST
  30. Widely Held Guru Stocks Trading In Europe

    GuruFocus | Sep. 22, 2014 | 17:56PM EST
  31. 3 Partnerships Pushing The Pharmaceutical Sector Forward

    Benzinga | Sep. 22, 2014 | 12:59PM EST
  32. Guru Stocks at 52-Week Lows: BHP, GSK, EC, VALE, ABB

    GuruFocus | Sep. 21, 2014 | 12:25PM EST
  33. China Fines Glaxo For Bribes

    IBD | Sep. 19, 2014 | 18:47PM EST
  34. Guru Stocks at 52-Week Lows: BHP, GSK, VOD, LYG, TEF

    GuruFocus | Sep. 16, 2014 | 12:27PM EST
  35. Stock Futures Down, But Not Far; Alibaba Sets IPO Price Range

    IBD | Sep. 8, 2014 | 09:07AM EST
  36. Benzinga's M&A Chatter for Wednesday August 27, 2014

    Benzinga | Aug. 27, 2014 | 20:45PM EST
  37. GSK Receives FDA Approval Of An Additional Promacta (eltrombopag) Indication For Use In Patients With Severe Aplastic Anaemia

    Benzinga | Aug. 26, 2014 | 15:56PM EST
  38. InterMune Stock Spikes On Rare Big Biotech Buyout

    IBD | Aug. 25, 2014 | 11:40AM EST
  39. 3 Dividend Kings From The U.K. I Love To Buy

    GuruFocus | Aug. 21, 2014 | 16:01PM EST
  40. UPDATE: GlaxoSmithKline Receives FDA Approval For Arnuity Ellipta In US For Treatment Of Asthma

    Benzinga | Aug. 20, 2014 | 15:36PM EST
  41. Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, MFG

    GuruFocus | Aug. 18, 2014 | 11:54AM EST
  42. Intermune up on buyout buzz

    IBD | Aug. 13, 2014 | 18:58PM EST
  43. You Should Consider Adding GlaxoSmithKline Based on Tremendous ROE

    GuruFocus | Aug. 8, 2014 | 10:57AM EST
  44. Drugmaker AstraZeneca Returns To Growth

    IBD | Aug. 5, 2014 | 17:22PM EST
  45. Widely Held Guru Stocks Near 52-Week Lows

    GuruFocus | Aug. 5, 2014 | 10:51AM EST
  46. Pfizer To Buy Baxter's Vaccines For $635 Million: The Positives & Negatives

    Benzinga | Aug. 5, 2014 | 09:16AM EST
  47. Glaxo, Sanofi Trend Up On Potential Deal For Established Brands

    Benzinga | Aug. 4, 2014 | 12:55PM EST
  48. Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, UBS

    GuruFocus | Aug. 4, 2014 | 11:12AM EST
  49. Glaxo, Genmab Report Positive Interim Result for Phase III Study of Ofatumumab

    Benzinga | Jul. 31, 2014 | 14:30PM EST
  50. A Look at the Week's Top Dividend Growers

    GuruFocus | Jul. 28, 2014 | 19:18PM EST
Trading Center